Literature DB >> 25770770

Undefined role of mucus as a barrier in ocular drug delivery.

Marika Ruponen1, Arto Urtti2.   

Abstract

Mucus layer covers the ocular surface, and soluble mucins are also present in the tear fluid. After topical ocular drug administration, the drugs and formulations may interact with mucus layer that may act as a barrier in ocular drug delivery. In this mini-review, we illustrate the mucin composition of the ocular surface and discuss the influence of mucus layer on ocular drug absorption. Based on the current knowledge the role of mucus barrier in drug delivery is still undefined. Furthermore, interactions with mucus may prolong the retention of drug formulations on the ocular surface. Mucus may decrease or increase ocular bioavailability depending on the magnitude of its role as barrier or retention site, respectively. Mechanistic studies are needed to clarify the role of mucin in ocular drug delivery.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conjunctival permeation; Corneal permeation; Mucin; Mucoadhesion; Mucus; Nanoparticle; Ocular drug delivery

Mesh:

Substances:

Year:  2015        PMID: 25770770     DOI: 10.1016/j.ejpb.2015.02.032

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

Review 1.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

Review 2.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 3.  Human ocular mucins: The endowed guardians of sight.

Authors:  Pablo Argüeso
Journal:  Adv Drug Deliv Rev       Date:  2021-12-04       Impact factor: 15.470

Review 4.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

5.  "Coffee Ring Effect" in Ophthalmology: "Anionic Dye Deposition" Hypothesis Explaining Normal Lid Margin Staining.

Authors:  Mohammad Taher Rajabi; Morteza Sharifzadeh
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye.

Authors:  Jin Li; Tongjie Cheng; Qiang Tian; Ying Cheng; Lixia Zhao; Xingzhen Zhang; Yi Qu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 7.  The utility and risks of therapeutic nanotechnology in the retina.

Authors:  Melanie Scheive; Saeed Yazdani; Amir R Hajrasouliha
Journal:  Ther Adv Ophthalmol       Date:  2021-03-22

8.  Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery.

Authors:  Carlo Astarita; Sara Palchetti; Mina Massaro-Giordano; Marina Di Domenico; Francesco Petrillo; Silvia Boffo; Giulio Caracciolo; Antonio Giordano
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

9.  Development and Evaluation of a Water Soluble Fluorometholone Eye Drop Formulation Employing Polymeric Micelle.

Authors:  Gyubin Noh; Taekwang Keum; Jo-Eun Seo; Jaewoong Choi; Bastola Rakesh; Lamichhane Shrawani; Byoungduck Park; Young Wook Choi; Sangkil Lee
Journal:  Pharmaceutics       Date:  2018-10-28       Impact factor: 6.321

Review 10.  Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.

Authors:  Rubén Varela-Fernández; Victoria Díaz-Tomé; Andrea Luaces-Rodríguez; Andrea Conde-Penedo; Xurxo García-Otero; Asteria Luzardo-Álvarez; Anxo Fernández-Ferreiro; Francisco J Otero-Espinar
Journal:  Pharmaceutics       Date:  2020-03-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.